CA1341391C - Peptides protecteurs derives de la gp160 du virus d'immunodeficience humaine-1 (vih-1) - Google Patents

Peptides protecteurs derives de la gp160 du virus d'immunodeficience humaine-1 (vih-1) Download PDF

Info

Publication number
CA1341391C
CA1341391C CA000597209A CA597209A CA1341391C CA 1341391 C CA1341391 C CA 1341391C CA 000597209 A CA000597209 A CA 000597209A CA 597209 A CA597209 A CA 597209A CA 1341391 C CA1341391 C CA 1341391C
Authority
CA
Canada
Prior art keywords
ile
gln
asn
lys
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000597209A
Other languages
English (en)
Inventor
Mark I. Greene
William Williams
David Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania
Original Assignee
University of Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania filed Critical University of Pennsylvania
Application granted granted Critical
Publication of CA1341391C publication Critical patent/CA1341391C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA000597209A 1988-04-20 1989-04-19 Peptides protecteurs derives de la gp160 du virus d'immunodeficience humaine-1 (vih-1) Expired - Fee Related CA1341391C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18384088A 1988-04-20 1988-04-20
US183,840 1988-04-20

Publications (1)

Publication Number Publication Date
CA1341391C true CA1341391C (fr) 2002-10-01

Family

ID=22674513

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000597209A Expired - Fee Related CA1341391C (fr) 1988-04-20 1989-04-19 Peptides protecteurs derives de la gp160 du virus d'immunodeficience humaine-1 (vih-1)

Country Status (7)

Country Link
KR (1) KR900700626A (fr)
AU (1) AU3557889A (fr)
CA (1) CA1341391C (fr)
IE (1) IE61966B1 (fr)
PT (1) PT90329B (fr)
WO (1) WO1989010416A1 (fr)
ZA (1) ZA892907B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
JPH06501260A (ja) * 1990-09-27 1994-02-10 シンテロ　ヴァクシーン　ディベロップメント　ケービー ヒト免疫不全ウィルスに対する中和抗体の誘発とワクチン接種に用いられるペプチド
US5840313A (en) * 1990-09-27 1998-11-24 Syntello Vaccine Development Kb Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
JPH06510025A (ja) * 1991-06-03 1994-11-10 シンテロ　ヴァクシン　デベロップメント　アクチ　ボラゲット Ｈｉｖ−１に対するｔ細胞活性化の誘導に用いられるペプチド
FR2677364A1 (fr) * 1991-06-05 1992-12-11 Pasteur Institut Sequences peptidiques de la glycoproteine externe d'enveloppe du retrovirus hiv-1.
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
GB2313376A (en) * 1996-05-22 1997-11-26 Diapharm Limited Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide (VIP)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743678A (en) * 1983-04-27 1988-05-10 President And Fellows Of Harvard College Method and products for detection of human T cell leukemia virus

Also Published As

Publication number Publication date
KR900700626A (ko) 1990-08-16
AU3557889A (en) 1989-11-24
IE891260L (en) 1989-10-20
PT90329A (pt) 1989-11-10
ZA892907B (en) 1990-03-28
WO1989010416A1 (fr) 1989-11-02
IE61966B1 (en) 1994-11-30
PT90329B (pt) 1994-09-30

Similar Documents

Publication Publication Date Title
KR100547049B1 (ko) 바이러스 감염증 치료를 위한 조성물 및 방법
US5166050A (en) Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
US8183354B2 (en) Virus coat protein/receptor chimeras and methods of use
KR100415423B1 (ko) gＣ1q수용체,이에결합하는ＨＩＶ-1gp120영역,및관련펩티드및표적항체
KR920008744B1 (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
US6908612B2 (en) Virus coat protein/receptor chimeras and methods of use
US5589175A (en) Peptides for induction of neutralizing antibodies against human immunodeficiency virus
US5777074A (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
US6042831A (en) Human immunodeficiency virus type 1 (HIV-1) GP160 epitopes that are immunologically homologous to epitopes located in the class I major histocompatibility complex (MHC) heavy chain α-1 domain
JP2598245B2 (ja) Ｈｔｌｖ−ｉｉｉ／ｌａｖウイルス関連ペプチドに対する抗体
US5338829A (en) Peptides derived from human immunodeficiency virus-1 GP160
IE891260L (en) PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY¹VIRUS-1 gp160
EP1137786A1 (fr) Chimeres de proteine d'enveloppe/recepteur de virus et methode d'utilisation
AU2006200454B2 (en) Compositions and methods for treating viral infections
EP0398707A1 (fr) Traitement et diagnostic des virus lymphotropiques humains
PL161520B1 (pl) Sposób wytwarzania nowego peptydu PL
AU2004208648A1 (en) Compositions and methods for treating infections
MXPA99003380A (en) Compositions and methods for treating viral infections
AU4087693A (en) HIV protein epitopes immunologically homologous to HLA

Legal Events

Date Code Title Description
MKLA Lapsed